These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12859188)

  • 21. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
    Orencia MC; Yoon JS; Ness JE; Stemmer WP; Stevens RC
    Nat Struct Biol; 2001 Mar; 8(3):238-42. PubMed ID: 11224569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural aspects for evolution of beta-lactamases from penicillin-binding proteins.
    Meroueh SO; Minasov G; Lee W; Shoichet BK; Mobashery S
    J Am Chem Soc; 2003 Aug; 125(32):9612-8. PubMed ID: 12904027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/beta-lactamase inhibitors.
    Silvaggi NR; Kaur K; Adediran SA; Pratt RF; Kelly JA
    Biochemistry; 2004 Jun; 43(22):7046-53. PubMed ID: 15170342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 beta-lactamase: 1.63 A crystal structure.
    Padayatti PS; Helfand MS; Totir MA; Carey MP; Hujer AM; Carey PR; Bonomo RA; van den Akker F
    Biochemistry; 2004 Feb; 43(4):843-8. PubMed ID: 14744126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs.
    Wang X; Minasov G; Shoichet BK
    J Mol Biol; 2002 Jun; 320(1):85-95. PubMed ID: 12079336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biophysical characterization of the interaction of the beta-lactamase TEM-1 with its protein inhibitor BLIP.
    Albeck S; Schreiber G
    Biochemistry; 1999 Jan; 38(1):11-21. PubMed ID: 9890878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
    Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T
    J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of antibiotic resistance: QM/MM modeling of the acylation reaction of a class A beta-lactamase with benzylpenicillin.
    Hermann JC; Hensen C; Ridder L; Mulholland AJ; Höltje HD
    J Am Chem Soc; 2005 Mar; 127(12):4454-65. PubMed ID: 15783228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
    Kumar S; Adediran SA; Nukaga M; Pratt RF
    Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure and kinetic analysis of beta-lactamase inhibitor protein-II in complex with TEM-1 beta-lactamase.
    Lim D; Park HU; De Castro L; Kang SG; Lee HS; Jensen S; Lee KJ; Strynadka NC
    Nat Struct Biol; 2001 Oct; 8(10):848-52. PubMed ID: 11573088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High level QM/MM modeling of the formation of the tetrahedral intermediate in the acylation of wild type and K73A mutant TEM-1 class A beta-lactamase.
    Hermann JC; Pradon J; Harvey JN; Mulholland AJ
    J Phys Chem A; 2009 Oct; 113(43):11984-94. PubMed ID: 19791786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases.
    Chen Y; Shoichet B; Bonnet R
    J Am Chem Soc; 2005 Apr; 127(15):5423-34. PubMed ID: 15826180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing active site chemistry in SHV beta-lactamase variants at Ambler position 244. Understanding unique properties of inhibitor resistance.
    Thomson JM; Distler AM; Prati F; Bonomo RA
    J Biol Chem; 2006 Sep; 281(36):26734-44. PubMed ID: 16803899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of the SHV-1 beta-lactamase.
    Kuzin AP; Nukaga M; Nukaga Y; Hujer AM; Bonomo RA; Knox JR
    Biochemistry; 1999 May; 38(18):5720-7. PubMed ID: 10231522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the wild-type TEM-1 beta-lactamase at 1.55 A and the mutant enzyme Ser70Ala at 2.1 A suggest the mode of noncovalent catalysis for the mutant enzyme.
    Stec B; Holtz KM; Wojciechowski CL; Kantrowitz ER
    Acta Crystallogr D Biol Crystallogr; 2005 Aug; 61(Pt 8):1072-9. PubMed ID: 16041072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant.
    Sun T; Bethel CR; Bonomo RA; Knox JR
    Biochemistry; 2004 Nov; 43(44):14111-7. PubMed ID: 15518561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of class D beta-lactamases by diaroyl phosphates.
    Majumdar S; Adediran SA; Nukaga M; Pratt RF
    Biochemistry; 2005 Dec; 44(49):16121-9. PubMed ID: 16331972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simulated annealing exploration of an active-site tyrosine in TEM-1 beta-lactamase suggests the existence of alternate conformations.
    Doucet N; Pelletier JN
    Proteins; 2007 Nov; 69(2):340-8. PubMed ID: 17600829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.